The Nominations Committee ensures that all ISUOG appointments, including of ISUOG Trustees, Officers & Committee Chairs, are made with integrity. It ensures that anyone who is put forward for election to any leadership position is of the right caliber and expertise to serve in the post. At the forefront of the appointments process is a demonstrated commitment to the vision and mission of the Society and consideration of the particular skills required for the roles in mind.
ISUOG Advisory Group, Scientific Committee, Nominations Committee, China Task Force, UOG Editorial Board
Professor Liona Poon is an Academic Subspecialist in Maternal Fetal Medicine, devoted in improving maternal and fetal health. She has had a prolific research output throughout her clinical and research posts, including over 130 peer-reviewed publications in high impact international journals. In the last 10 years she has focused her research on establishing a programme for effective early prediction and prevention of preeclampsia, a major cause of maternal and perinatal morbidity and mortality. With her success in developing a first-trimester prediction model for preeclampsia using maternal risk factors, ultrasound, blood pressure and biochemical markers, and on Aspirin prophylaxis against preeclampsia, her goal in the next 10 years is to improve obstetric care worldwide, through clinical research and education.
Aspire trial: incidence of preterm preeclampsia in patients fulfulling ACOG and NICE criteria according to risk by the FMF algorithm. Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nikolaides KH.
Ultrasound Obstet Gynecol 2018 Jan 30. doi: 10.1002/uog.19019 [Epub ahead of print]
Aspirin versus Placebo in Pregnancies at High Risk of Preterm Preeclampsia. Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tennebaum Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides K.H.
New England Journal Medicine 2017, 2017 Jun 28. doi: 10.1056/NEJMoa1704559. [Epub ahead of print]
Country: China, Hong Kong Special Administrative Region
Specialties: Fetal anomaly screening 1st trimester and 2nd trimester; fetal biometry and wellbeing; fetal anomalies screening; aneuploidy screening; fetal anomalies; fetal growth restriction; maternal and fetal Doppler; multiple pregnancy; preeclampsia; preterm delivery; fetal growth; detection of fetal and neonatal growth abnormalities; ultrasound on the labour ward
Languages: English; Chinese (Mandarin); Chinese (Cantonese)
ISUOG Advisory Group, Honours Committee, 3D Special Interest Group
Dr Reem S. Abu-Rustum obtained her medical degree and completed her residency training at the University of Florida (USA). She is a fellow of the American College of OB/GYN (ACOG), the American Institute of Ultrasound in Medicine (AIUM) and the American College of Surgeons. She is certified by the Fetal Medicine Foundation in first and second trimester ultrasound.
She is ISUOG's Ambassador to Outreach in Lebanon and the Middle East, Chair of ISUOG's Basic Training Task Force, a member ISUOG's Outreach Committee and a member of ISUOG's 3D Special Interest Group. She serves as Co-Chair of the AIUM Annual Convention Committee, is a member of the Editorial Advisory Board of the Journal of Ultrasound in Medicine, is a member of the Society of Maternal Fetal Medicine's Education and Global Health Committees, and is a member of the Fetal Heart Society's Education Committee. She is Editor-in-Chief of the quarterly newsletter of the Centre for Advanced Fetal Care. She served as a member of the Editorial Review Board for the AIUM OBGYN Ultrasound Lecture Series and currently serves on the SMFM-AIUM Task force on Curriculum Development and Competency Assessment Tools for MFM Fellowship Training.
She has authored the text "A Practical Guide to 3D Ultrasound" (CRC Press 2014). Her primary areas of interest are the first trimester fetus and the fetal heart. She is also actively involved in the integration of ultrasound in medical education and is the co-founder and President of SANA Medical NGO, which is dedicated to obstetrical care within an outreach setting.
She is an Associate Professor of Maternal Fetal Medicine at the University of Florida.
Abu-Rustum RS, Ziade MF. The 3 sweep approach for fetal anatomic assessment in the outreach setting. Journal of Fetal Medicine 2017; 4(1): 25-30.
Abu-Rustum RS, Ziade MF, Abu-Rustum SE, Danawi H. The Role of Ultrasound in the Lebanese Outreach Setting. International Journal of Childbirth Education. 2015; 30(2): 43-48.
Abu-Rustum RS. A Practical Guide to 3D Ultrasound. First Edition. CRC Press. 9 Dec 2014.
Abu-Rustum RS, Ziade MF, Abu-Rustum SE. Reference values for the right and left fetal choroid plexus at 11-13 weeks: an early sign of ‘developmental’ laterality? J. Ultrasound Med 2013; 32: 1623-1629.
Specialties: Fetal anomaly screening 1st trimester and 2nd trimester; aneuploidy screening; fetal heart; 3D & 4D ultrasound; basic training; the first trimester fetus; ultrasound in medical education.
Languages: English; Arabic
"My ISUOG membership over the past decade has empowered me to establish SANA Medical NGO in North Lebanon, modelled on ISUOG Outreach. This has been a most gratifying experience: spreading ISUOG's teachings and providing training to midwives and nurses in our neediest underserved areas. Our trainees are now enabled to provide comprehensive antenatal care, positively impacting the lives of under-resourced Lebanese mothers as well as Syrian refugees."
2020 Virtual Congress Technical Congress Chair, Bids Committee, Executive Committee, Finance & Risk Committee, Nominations Committee, ISUOG Advisory Group
Professor Tom Bourne
ISUOG President 2020 - 2022, Virtual World Congress Technical Congress Chair 2020 and 2021, 2022 World Congress Co-Chair, Executive Committee, Bids Committee, Finance & Risk Committee, Nominations Committee
Professor Tom Bourne was ISUOG President between 2020 and 2022 and is curently Chair in Gynaecology at Imperial College London, Hon Consultant Gynaecologist at Queen Charlottes and Chelsea hospital and Visiting Professor at KU Leuven in Belgium. He is an authority on managing early pregnancy complications, emergency gynaecology and gynaecological ultrasonography. He trained in ultrasound at Kings College Hospital in London. He subsequently worked at the University of Göteborg, Sweden as Medical Research Council visiting scientist, Hamar in Norway, and Leuven in Belgium. He was appointed senior lecturer and consultant gynaecologist at St George's University Hospital London before moving to Imperial College. He has edited seven books and published over 400 papers. He sits on the management committee of the Tommy’s National Centre for Miscarriage Research. He is medical advisor and trustee of the patient group, the Ectopic Pregnancy Trust. He is immediate Past-President of the UK Association of Early Pregnancy Units. He is co-founder and CEO of the International Ovarian Tumor Analysis (IOTA) group and sits on the steering committees of several large multicentre international trials. He is founder member of the RCOG task force on “supporting our doctors”. He is honorary fellow of the American Institute of Ultrasound in Medicine, honorary member of the Australasian Society for Ultrasound in Medicine and honorary member of the Brazilian and Hungarian Ultrasound Societies.
His principal research interest is diagnostics in early pregnancy and gynaecology including the IOTA, IETA, IDEA and MUSA studies, microbiome, metabolomics, novel biomarkers, and AI. His interests include the psychology of pregnancy loss and physician welfare including studies with the BMA and RCOG.
Specialties: Early Pregnancy Care, Emergency Gynaecology, Ultrasound in Oncology, Gynaecological Ultrasonography, Physician Wellbeing
Selected Notable Publications:
Sporadic miscarriage: evidence to provide effective care. Coomarasamy A, Gallos ID, Papadopoulou A, Dhillon-Smith RK, Al-Memar M, Brewin J, Christiansen OB, Stephenson MD, Oladapo OT, Wijeyaratne CN, Small R, Bennett PR, Regan L, Goddijn M, Devall AJ, Bourne T, Brosens JJ, Quenby S.
Lancet. 2021 May 1;397(10285):1668-1674. doi: 10.1016/S0140-6736(21)00683-8. Epub 2021 Apr 27.
Van Calster B, Valentin L, Froyman W, Landolfo C, Ceusters J, Testa AC, Wynants L, Sladkevicius P, Van Holsbeke C, Domali E, Fruscio R, Epstein E, Franchi D, Kudla MJ, Chiappa V, Alcazar JL, Leone FPG, Buonomo F, Coccia ME, Guerriero S, Deo N, Jokubkiene L, Savelli L, Fischerová D, Czekierdowski A, Kaijser J, Coosemans A, Scambia G, Vergote I, Bourne T, Timmerman D.
BMJ. 2020 Jul 30;370:m2614. doi: 10.1136/bmj.m2614.
Farren J, Jalmbrant M, Falconieri N, Mitchell-Jones N, Bobdiwala S, Al-Memar M, Tapp S, Van Calster B, Wynants L, Timmerman D, Bourne T.
Am J Obstet Gynecol. 2020 Apr; 222(4):367.e1-367.e22. doi: 10.1016/j.ajog.2019.10.102.
Froyman W, Landolfo C, De Cock B, Wynants L, Sladkevicius P, Testa AC, Van Holsbeke C, Domali E, Fruscio R, Epstein E, Dos Santos Bernardo MJ, Franchi D, Kudla MJ, Chiappa V, Alcazar JL, Leone FPG, Buonomo F, Hochberg L, Coccia ME, Guerriero S, Deo N, Jokubkiene L, Kaijser J, Coosemans A, Vergote I, Verbakel JY, Bourne T, Van Calster B, Valentin L, Timmerman D.
Lancet Oncol. 2019 Mar; 20(3): 448-458. doi: 10.1016/S1470-2045(18)30837-4.
Defining safe criteria to diagnose miscarriage: prospective observational multicentre study. Preisler J, Kopeika J, Ismail L, Vathanan V, Farren J, Abdallah Y, Battacharjee P, Van Holsbeke C, Bottomley C, Gould D, Johnson S, Stalder C, Van Calster B, Hamilton J, Timmerman D, Bourne T.
BMJ. 2015 Sep 23; 351:h4579. doi: 10.1136/bmj.h4579.
Evaluating the risk of ovarian cancer before surgery using the ADNEX model to differentiate between benign, borderline, early and advanced stage invasive, and secondary metastatic tumours: prospective multicentre diagnostic studies. Van Calster B, Van Hoorde K, Valentin L, Testa AC, Fischerova D, Van Holsbeke C, Savelli L, Franchi D, Epstein E, Kaijser J, Van Belle V, Czekierdowski A, Guerriero S, Fruscio R, Lanzani C, Scala F, Bourne T, Timmerman D; International Ovarian Tumour Analysis Group.
BMJ. 2014 Oct 15;349:g5920. doi: 10.1136/bmj.g5920.
Diagnostic criteria for nonviable pregnancy early in the first trimester. Doubilet PM, Benson CB, Bourne T, Blaivas M; Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy, Barnhart KT, Benacerraf BR, Brown DL, Filly RA, Fox JC, Goldstein SR, Kendall JL, Lyons EA, Porter MB, Pretorius DH, Timor-Tritsch IE.
N Engl J Med. 2013 Oct 10; 369(15): 1443-51. doi: 10.1056/NEJMra1302417.
Limitations of current definitions of miscarriage using mean gestational sac diameter and crown-rump length measurements: a multicenter observational study. Abdallah Y, Daemen A, Kirk E, Pexsters A, Naji O, Stalder C, Gould D, Ahmed S, Guha S, Syed S, Bottomley C, Timmerman D, Bourne T.
Ultrasound Obstet Gynecol. 2011 Nov; 38(5): 497-502. doi: 10.1002/uog.10109.
He is President of the UK Association of Early Pregnancy Units (AEPU), Trustee of the Ectopic Pregnancy Trust and on the steering committee of the International Ovarian Tumor Analysis (IOTA) trial.
Patient Information Task Force (Chair), Education Committee, Nominations Committee
Dr Alain Gagnon is a Clinical Professor of Obstetrics and Gynecology at UBC. He practices maternal-fetal medicine and is currently a Senior Medical Director for the Ambulatory Programs at BC Women's. He performed the first laser surgery for TTTS in Canada.
Audibert F, Gagnon A + SOGC Genetics Committee. “Prenatal Screening for and Diagnosis of Aneuploidy in Twin Pregnancies.” J Obstet Gynaecol Can 2011;33(7):754-767.
Gagnon A and the SOGC Genetics Committee. “Evaluation of Prenatally Diagnosed Structural Congenital Anomalies”. J Obstet Gynaecol Can 2009;31(9):875-881.
Specialties: Fetal anomaly screening T2; fetal biometry and wellbeing; aneuploidies; fetal anomalies; fetal interventional procedures; multiple pregnancy; genetics
Languages: French; English
ISUOG Advisory Group
Prof. Jon Hyett trained in obstetrics and gynecology and sub-specialised in maternal and fetal medicine in the UK. He is currently Joint Head of the Discipline of Obstetrics, Gynaecology and Neonataology at the University of Sydney. He is involved nationally with the Nuchal Translucency Accreditation Program of RANZCR / RANZCOG and internationally with the obstetric ultrasound accreditation programs run by the Fetal Medicine Foundation, UK and ISUOG. Jon is also involved in the Scientific Committee, which oversees the production and development of the scientific program for the ISUOG World Congress.
Specialties: Fetal anomaly screening T1 & T2; fetal biometry and wellbeing; aneuploidies; fetal anomalies; fetal heart; fetal brain; fetal growth restriction; maternal and fetal Doppler; fetal interventional procedures; multiple pregnancy; preeclampsia; preterm delivery; genetics
ISUOG Advisory Group, Executive Committee, Finance & Risk Committee, Nominations Committee, Fetal MRI Focus Group, UOG Editorial Board
Prof. Laurent Salomon is a senior consultant in the Department of Obstetrics and Fetal Medicine at Necker-Enfants-Malades Hospital and full professor at Paris Descartes University. His special interests are imaging technologies including MRI, Twins, Fetal surgery, Statistics, Teaching processes and Quality control. Laurent completed a PhD in Physics with distinction (Paris XI Sud, Science University – Orsay), applied to Functional Magnetic Resonance Imaging of the placenta. He also completed a MSc in Medical Statistic with distinction at the London School of Hygiene and Tropical Medicine (LSHTM).
Laurent is an associate director of a Master Degree in Prenatal Diagnosis and Fetal Medicine at Paris Descartes University. He is on the Editorial Board of Ultrasound in Obstetrics and Gynecology and involved in many committees and task forces of ISUOG. Laurent also serves on a regular basis as an expert for the National Agency for Biomedicine, French Health Authority and National Security Agency in Health Products, as well as for international research projects.
Field: Obstetrics; Imaging; Fetal Medicine
Specialties: Fetal anomaly screening T1 & T2; fetal biometry and wellbeing; aneuploidies; fetal anomalies; fetal growth restriction; maternal and fetal Doppler; fetal interventional procedures; multiple pregnancy
Languages: English; French